HRP20041208A2 - Pyrrolidine derivatives as oxytocin antagonists - Google Patents
Pyrrolidine derivatives as oxytocin antagonistsInfo
- Publication number
- HRP20041208A2 HRP20041208A2 HR20041208A HRP20041208A HRP20041208A2 HR P20041208 A2 HRP20041208 A2 HR P20041208A2 HR 20041208 A HR20041208 A HR 20041208A HR P20041208 A HRP20041208 A HR P20041208A HR P20041208 A2 HRP20041208 A2 HR P20041208A2
- Authority
- HR
- Croatia
- Prior art keywords
- sub
- pyrrolidine derivatives
- oxytocin antagonists
- sup
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02100784 | 2002-07-05 | ||
PCT/EP2003/050286 WO2004005249A1 (en) | 2002-07-05 | 2003-07-04 | Pyrrolidine derivatives as oxytocin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20041208A2 true HRP20041208A2 (en) | 2005-06-30 |
Family
ID=30011225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20041208A HRP20041208A2 (en) | 2002-07-05 | 2004-12-23 | Pyrrolidine derivatives as oxytocin antagonists |
Country Status (20)
Country | Link |
---|---|
US (1) | US7115754B2 (xx) |
EP (1) | EP1532109B1 (xx) |
JP (1) | JP4851085B2 (xx) |
CN (1) | CN1330633C (xx) |
AT (1) | ATE442354T1 (xx) |
BR (1) | BR0312586A (xx) |
CA (1) | CA2487532C (xx) |
DE (1) | DE60329189D1 (xx) |
EA (1) | EA008479B1 (xx) |
ES (1) | ES2330841T3 (xx) |
HK (1) | HK1076107A1 (xx) |
HR (1) | HRP20041208A2 (xx) |
IL (1) | IL166103A0 (xx) |
MX (1) | MXPA05000326A (xx) |
NO (1) | NO20050612L (xx) |
PL (1) | PL374666A1 (xx) |
RS (1) | RS115804A (xx) |
UA (1) | UA78058C2 (xx) |
WO (1) | WO2004005249A1 (xx) |
ZA (1) | ZA200409820B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL159219A0 (en) * | 2001-06-18 | 2004-06-01 | Applied Research Systems | Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them |
US10722645B2 (en) | 2011-12-21 | 2020-07-28 | Deka Products Limited Partnership | Syringe pump, and related method and system |
EP2845850A1 (en) * | 2013-09-10 | 2015-03-11 | ObsEva S.A. | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists |
EP2886107A1 (en) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Oral formulations of pyrrolydine derivatives |
MX371068B (es) | 2014-07-02 | 2020-01-15 | ObsEva SA | ((3z,5s)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil ]pirrolidin-3-ona o-metiloxima cristalina y métodos de uso de la misma. |
EP3501533A1 (en) | 2014-12-22 | 2019-06-26 | Ferring B.V. | Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies |
JP6933322B2 (ja) | 2016-01-04 | 2021-09-08 | メルク セローノ エス.エー. | ヒドロキシプロピルチアゾリジンカルボキサミド誘導体のl−バリネート及びその塩形態、結晶多形 |
UA127283C2 (uk) | 2016-07-21 | 2023-07-12 | Обсева С.А. | Спосіб застосування антагоніста окситоцину для сприяння імплантації ембріона і запобігання викидню |
CN114667141A (zh) | 2019-09-03 | 2022-06-24 | 奥布赛瓦股份公司 | 用于促进胚胎移植和预防流产的催产素拮抗剂给药方案 |
AU2021218895A1 (en) | 2020-02-10 | 2022-09-15 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
BR0109900A (pt) * | 2000-03-27 | 2003-06-03 | Applied Research Systems | Derivados de pirolidina farmaceuticamente ativos, uso de derivados de pirolidina, composição farmacêutica e processo para preparação de um derivado de pirolidina |
-
2003
- 2003-04-07 UA UA20041210895A patent/UA78058C2/uk unknown
- 2003-07-04 CA CA2487532A patent/CA2487532C/en not_active Expired - Fee Related
- 2003-07-04 CN CNB038204010A patent/CN1330633C/zh not_active Expired - Fee Related
- 2003-07-04 US US10/518,543 patent/US7115754B2/en not_active Expired - Lifetime
- 2003-07-04 ES ES03762692T patent/ES2330841T3/es not_active Expired - Lifetime
- 2003-07-04 PL PL03374666A patent/PL374666A1/xx not_active Application Discontinuation
- 2003-07-04 JP JP2004518783A patent/JP4851085B2/ja not_active Expired - Fee Related
- 2003-07-04 BR BR0312586-6A patent/BR0312586A/pt not_active IP Right Cessation
- 2003-07-04 EP EP03762692A patent/EP1532109B1/en not_active Expired - Lifetime
- 2003-07-04 MX MXPA05000326A patent/MXPA05000326A/es active IP Right Grant
- 2003-07-04 AT AT03762692T patent/ATE442354T1/de not_active IP Right Cessation
- 2003-07-04 RS YUP-1158/04A patent/RS115804A/sr unknown
- 2003-07-04 WO PCT/EP2003/050286 patent/WO2004005249A1/en active Application Filing
- 2003-07-04 EA EA200500133A patent/EA008479B1/ru not_active IP Right Cessation
- 2003-07-04 DE DE60329189T patent/DE60329189D1/de not_active Expired - Lifetime
-
2004
- 2004-12-03 ZA ZA200409820A patent/ZA200409820B/en unknown
- 2004-12-23 HR HR20041208A patent/HRP20041208A2/xx not_active Application Discontinuation
-
2005
- 2005-01-03 IL IL16610305A patent/IL166103A0/xx unknown
- 2005-02-03 NO NO20050612A patent/NO20050612L/no not_active Application Discontinuation
- 2005-11-17 HK HK05110274A patent/HK1076107A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0312586A (pt) | 2005-04-12 |
ATE442354T1 (de) | 2009-09-15 |
DE60329189D1 (de) | 2009-10-22 |
CA2487532A1 (en) | 2004-01-15 |
US7115754B2 (en) | 2006-10-03 |
US20060004020A1 (en) | 2006-01-05 |
EP1532109A1 (en) | 2005-05-25 |
PL374666A1 (en) | 2005-10-31 |
NO20050612L (no) | 2005-02-03 |
MXPA05000326A (es) | 2005-03-31 |
WO2004005249A1 (en) | 2004-01-15 |
EA008479B1 (ru) | 2007-06-29 |
UA78058C2 (en) | 2007-02-15 |
RS115804A (xx) | 2007-02-05 |
ZA200409820B (en) | 2006-07-26 |
JP4851085B2 (ja) | 2012-01-11 |
HK1076107A1 (en) | 2006-01-06 |
CA2487532C (en) | 2011-03-08 |
JP2005533828A (ja) | 2005-11-10 |
CN1330633C (zh) | 2007-08-08 |
CN1678576A (zh) | 2005-10-05 |
EP1532109B1 (en) | 2009-09-09 |
EA200500133A1 (ru) | 2005-08-25 |
IL166103A0 (en) | 2006-01-15 |
AU2003254498A1 (en) | 2004-01-23 |
ES2330841T3 (es) | 2009-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076107A1 (en) | Pyrrolidine derivatives as oxytocin antagonists | |
NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
BR0314688A (pt) | Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina | |
EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
ATE357434T1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
AR041298A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
TR200000670T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
SE0200919D0 (sv) | Chemical compounds | |
EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
NO20076000L (no) | Aminosyrederivater | |
ES2202156T3 (es) | Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f. | |
NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
DE50304891D1 (de) | N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel | |
WO2001070693A3 (en) | Difluorobutyric acid derivatives and their use as metalloprotease inhibitors | |
WO2002046152A3 (de) | Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben | |
IL153784A0 (en) | Novel n-(2-phenyl-3-aminopropyl) naphthamides | |
NO20052413L (no) | Substituted aralkyl derivatives | |
SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
ATE364039T1 (de) | Bis-dicarbonsäuresalze von benazepril und herstellung von benazepril über diese salze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20070924 Year of fee payment: 5 |
|
OBST | Application withdrawn |